(Q40573107)

21 September 2017

title

Efficacy and safety of gatifloxacin in elderly outpatients with community-acquired pneumonia (English)

1 reference

21 September 2017

Susan C Nicholson

1

1 reference

21 September 2017

Walter R Wilson

2

1 reference

21 September 2017

Bruce J Naughton

3

1 reference

21 September 2017

Samantha Gothelf

4

1 reference

21 September 2017

C Douglas Webb

5

1 reference

21 September 2017

language of work or name

1 reference

1 September 2002

1 reference

Diagnostic Microbiology and Infectious Disease

21 September 2017

published in

1 reference

21 September 2017

volume

44

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

117-125

1 reference

A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Pneumonia in the elderly: overview of diagnostic and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

An update on community-acquired pneumonia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Management of pneumonia in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Quinolones in the aged

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Gatifloxacin in community-based treatment of acute respiratory tract infections in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Pneumococcal vaccination: current and future issues

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Prospective study of lower respiratory tract infections in an extended-care nursing home program: potential role of oral ciprofloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

Antibiotic agents in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900465-0

7 January 2021

10.1016/S0732-8893(02)00465-0

Identifiers

DOI

1 reference

release_mtumotdptvashga63xing7wcri

21 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mtumotdptvashga63xing7wcri

24 November 2022

mapped directly with Wikidata item

1 reference